SCHEMBL661273

SCHEMBL661273

CC(C)OC(=O)C1=CN(CC(=O)c2ccc(Cl)cc2Cl)C=CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.43
ALDH1A1 P00352 4/20 0.43
SMN1; SMN2 Q16637 1/20 0.42
MAPK1 P28482 1/20 0.41
HIF1A Q16665 1/20 0.41
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
ERCC5 P28715 1/20 0.38
FEN1 P39748 1/20 0.38
CA12 O43570 1/20 0.37
CA1 P00915 1/20 0.37
PAX8 Q06710 1/20 0.37
KLF5 Q13887 1/20 0.37
CA9 Q16790 1/20 0.37
POLB P06746 1/20 0.37
LMNA P02545 2/20 0.36
MAPT P10636 1/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
AGTR1 P30556 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL660547 0.83 ALDH1A1 (0.39) ALDH1A1MAPK1HIF1AMEN1KMT2A
SCHEMBL662087 0.82 KMT2A (0.47) ALDH1A1MAPK1HIF1AKMT2APOLB
SCHEMBL660255 0.81 ALDH1A1 (0.47) ALDH1A1SMN1; SMN2MAPK1HIF1AMEN1
SCHEMBL287385 0.80 ALDH1A1 (0.46) HPGDALDH1A1SMN1; SMN2MAPK1HIF1A
SCHEMBL7808649 0.79 ALDH1A1 (0.42) HPGDALDH1A1MAPK1HIF1AMEN1
SCHEMBL661570 0.75 ALDH1A1 (0.51) HPGDALDH1A1MAPK1HIF1AKMT2A
SCHEMBL661083 0.75 ALDH1A1 (0.39) ALDH1A1MAPK1HIF1AMEN1KMT2A
SCHEMBL286986 0.74 MAPT (0.46) ALDH1A1SMN1; SMN2MAPK1MEN1KMT2A
SCHEMBL9249536 0.73 HPGD (0.57) HPGDALDH1A1SMN1; SMN2MAPK1HIF1A
SCHEMBL660293 0.70 HPGD (0.46) HPGDALDH1A1MAPK1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120046317-A1 NOVEL HETEROCYCLIC COMPOUNDS DUTT CHAITANYA (IN) 2012-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046317-A1 NOVEL HETEROCYCLIC COMPOUNDS AGER, REN, AGT HPGD 202/4885ALDH1A1 676/4885SMN1; SMN2 640/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.